Microbial pathogenesis

clinical immunology (orlando, fla)

Journal of the American Academy of Dermatology

journal of thoracic oncology : official publication of the international association for the study of lung cancer

[1] Shell disorder analysis predicts greater resilience of the SARS-CoV-2 (COVID-19) outside the body and in body fluids.

[2] Use of Systemic Immunomodulatory Therapies During the Coronavirus Disease 2019 (COVID-19) Pandemic.

[3] Patients with advanced basal cell carcinomas in treatment with sonic hedgehog inhibitors during the coronavirus disease 2019 (COVID-19) period: Management and adherence to treatment.

[4] COVID-19 - Considerations for the paediatric rheumatologist.

[5] Early appearance of COVID-19 associated pulmonary infiltrates during daily radiotherapy imaging for lung cancer.

[6] COVID-19 or Lung Cancer: what should we treat?

[7] In-house responses and anxiety levels of commercial kitchen employees towards new COVID 19 food safety regulations

[8] Insight into COVID-2019 for pediatricians.

[9] Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020.

[10] Understanding Unreported Cases in the COVID-19 Epidemic Outbreak in Wuhan, China, and the Importance of Major Public Health Interventions.

[11] [A pathological report of three COVID-19 cases by minimally invasive autopsies].

[12] Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms.

[13] Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19).

[14] Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases

[15] COVID-19 - what should anaethesiologists and intensivists know about it?

[16] COVID-19 epidemic in Switzerland: on the importance of testing, contact tracing and isolation.

[17] Evaluation of the Effectiveness of Surveillance and Containment Measures for the First 100 Patients with COVID-19 in Singapore - January 2-February 29, 2020.

[18] Initial Investigation of Transmission of COVID-19 Among Crew Members During Quarantine of a Cruise Ship - Yokohama, Japan, February 2020.

[19] WHO Declares COVID-19 a Pandemic.

[20] The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks.

[21] Artificial Intelligence Distinguishes COVID-19 from Community Acquired Pneumonia on Chest CT.

[22] Temporal Changes of CT Findings in 90 Patients with COVID-19 Pneumonia: A Longitudinal Study.

[23] COVID-2019 and Pregnancy: A plea for transparent reporting of all cases.

[24] COVID-19 pandemic: perspectives on an unfolding crisis.

[25] Securing the Safety Net and Protecting Public Health During a Pandemic: Medicaid's Response to COVID-19.

[26] Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State.

[27] Serial Interval of COVID-19 among Publicly Reported Confirmed Cases.

[28] COVID-19: What implications for sexual and reproductive health and rights globally?

[29] Should patients stop their biologic treatment during the COVID-19 pandemic.

[30] From SARS to COVID-19: A previously unknown SARS- related coronavirus (SARS-CoV-2) of pandemic potential infecting humans – Call for a One Health approach

[31] Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis

[32] Iranian mental health during the COVID-19 epidemic

[33] Clinical considerations for patients with diabetes in times of COVID-19 epidemic

[34] Traditional Chinese medicine for COVID-19 treatment

[35] Anti-HCV, nucleotide inhibitors, repurposing against COVID-19

[36] Of chloroquine and COVID-19

[37] Diabetes and COVID-19

[38] How health anxiety influences responses to viral outbreaks like COVID-19: What all decision-makers, health authorities, and health care professionals need to know

[39] The coronavirus (COVID-19) epidemic and patient safety

[40] A conceptual model for the coronavirus disease 2019 (COVID-19) outbreak in Wuhan, China with individual reaction and governmental action

[41] Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: A data-driven analysis

[42] Li Wenliang, a face to the frontline healthcare worker. The first doctor to notify the emergence of the SARS-CoV-2, (COVID-19), outbreak

[43] World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19)

[44] The response of Milan's Emergency Medical System to the COVID-19 outbreak in Italy

[45] Are high-performing health systems resilient against the COVID-19 epidemic?

[46] COVID-19: the gendered impacts of the outbreak

[47] Looming threat of COVID-19 infection in Africa: act collectively, and fast

[48] Lessons for managing high-consequence infections from first COVID-19 cases in the UK

[49] COVID-19 and the anti-lessons of history

[50] COVID-19: preparing for superspreader potential among Umrah pilgrims to Saudi Arabia

[51] Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study

[52] One world, one health: The novel coronavirus COVID-19 epidemic

[53] COVID-19: too little, too late?

[54] Statement in support of the scientists, public health professionals, and medical professionals of China combatting COVID-19

[55] Real-time forecasts of the COVID-19 epidemic in China from February 5th to February 24th, 2020

[56] What further should be done to control COVID-19 outbreaks in addition to cases isolation and contact tracing measures?

[57] COVID-19 prevention and control recommendations for the ICU

[58] Communicating the Risk of Death from Novel Coronavirus Disease (COVID-19)

[59] Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (COVID-19) Epidemic among the General Population in China

[60] Global spread of COVID-19 and pandemic potential

[61] Assessing the Impact of Reduced Travel on Exportation Dynamics of Novel Coronavirus Infection (COVID-19)

[62] Going viral – Covid-19 impact assessment: A perspective beyond clinical practice

[63] Alert for non-respiratory symptoms of Coronavirus Disease 2019 (COVID-19) patients in epidemic period: A case report of familial cluster with three asymptomatic COVID-19 patients.

[64] Transmission potential of the novel coronavirus (COVID-19) onboard the diamond Princess Cruises Ship, 2020.

[65] SARS-CoV-2 and COVID-19: The most important research questions.

[66] There may be virus in conjunctival secretion of patients with COVID-19.

[67] Internationally lost COVID-19 cases.

[68] Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics.

[69] Challenges and Countermeasures of Integrative Cancer Therapy in the Epidemic of COVID-19.

[70] Undocumented U.S. Immigrants and Covid-19.

[71] Artificial Intelligence and Machine Learning to Fight COVID-19.

[72] [Follow-up testing of viral nucleic acid in discharged patients with moderate type of 2019 coronavirus disease (COVID-19)].

[73] Consensus guidelines for managing the airway in patients with COVID-19.

[74] [Dealing with psychological distress by healthcare professionals during the COVID-19 pandemia].

[75] Geriatric Care during Public Health Emergencies: Lessons Learned from Novel Corona Virus Disease (COVID-19) Pandemic.

[76] The Trial of Chloroquine in the Treatment of Corona Virus Disease 2019 （COVID-19） and Its Research Progress in Forensic Toxicology.

[77] Coronavirus (Covid-19) outbreak on the cruise ship Diamond Princess.

[78] Novel coronavirus disease (COVID-19) outbreak: Now is the time to refresh pandemic plans.

[79] The effectiveness of the quarantine of Wuhan city against the Corona Virus Disease 2019 (COVID-19): well-mixed SEIR model analysis.

[80] Positive Externalities of an Epidemic: The Case of the Corona Virus (COVID-19) in China.

[81] A consensus statement on the use of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in relation to COVID-19 (corona virus disease 2019).

[82] The versatile heparin in COVID-19.

[83] Response to: Sore throat in COVID-19: comment on "Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: A single arm meta-analysis".

[84] Vertical Transmission of Coronavirus Disease 19 (COVID-19) from Infected Pregnant Mothers to Neonates: A Review.

[85] A case of imported COVID-19 diagnosed by PCR-positive lower respiratory specimen but with PCR-negative throat swabs.

[86] Corona Virus (COVID-19) "Infodemic" and Emerging Issues through a Data Lens: The Case of China.

[87] A Comparative Study of Chest Computed Tomography Features in Young and Older Adults With Corona Virus Disease (COVID-19).

[88] Complex emergencies of COVID-19: management and experience in Zhuhai.

[89] Temporary Emergency Guidance to US Stroke Centers During the COVID-19 Pandemic.

[90] CD-sACE2 Inclusion Compounds: An Effective Treatment for Corona Virus Disease 2019 (COVID-19).

[91] Clinical and Transmission Characteristics of Covid-19 - A Retrospective Study of 25 Cases from a Single Thoracic Surgery Department.

[92] The COVID-19 Intubation and Ventilation Pathway (CiVP); a Commentary.

[93] Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis.

[94] Emerging prophylaxis strategies against COVID-19.

[95] COVID-19 and chronological aging: senolytics and other anti-aging drugs for the treatment or prevention of corona virus infection?

[96] The different clinical characteristics of corona virus disease cases between children and their families in China - the character of children with COVID-19

[97] Novel corona virus disease (COVID-19) in pregnancy: What clinical recommendations to follow?

[98] Dynamic changes of chest CT imaging in patients with corona virus disease-19 (COVID-19)

[99] Management of corona virus disease-19 (COVID-19): the Zhejiang experience

[100] [Comparison of two epidemic patterns of COVID-19 and evaluation of prevention and control effectiveness: an analysis based on Guangzhou and Wenzhou].

[101] [Epidemiological characteristics of COVID-19 in Shaanxi province].